P-4 Evaluating therapy outcome in Mysthenia Gravis
نویسندگان
چکیده
P-3 Exercise intolerance in Mc Ardle Disease: functional and metabolic evaluation F. Bertolucci, G. Ricci, R. Papi, F. Franzoni, F. Galetta, G. Bigalli, M.C. Zecca, G. Tartarisco, C. Masoni, A. Lo Gerfo, G. Siciliano Department of Neuroscience and 1 Department of Internal Medicine, University of Pisa, Italy; 2 Unit of Cardiovascular Medicine, S. Chiara Hospital, Pisa, Italy; 3 Institute of Clinical Physiology, CNR, Pisa, Italy
منابع مشابه
Evaluating the Need for Prophylactic Antibiotic Therapy in Infants with Transient Tachypnea of the Newborn: A Triple-Blind Randomized Clinical Trial Study
Background Transient tachypnea of the newborn (TTN) is a respiratory disorder caused by delay in the evacuation of the lung fluids. Prophylactic antibiotic therapy is recommended for the risk of sepsis. We aimed to evaluate the effect of the prophylactic antibiotic in infants with TTN. Materials and Methods This randomized clinical trial study was conducted on all infants, admitted to TTN at F...
متن کاملSubcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study
BACKGROUND Immunoglobulin therapy has become a major treatment option in several autoimmune neuromuscular disorders. For patients with Myasthenia Gravis (MG), intravenous immunoglobulin (IVIg) has been used for both crisis and chronic management. Subcutaneous Immunoglobulins (SCIg), which offer the advantage of home administration, may be a practical and effective option in chronic management o...
متن کاملParaneoplastic Autoimmunity in Thymus Tumors
Autoimmune phenomena are more frequent in thymic epithelial tumors (TET) than in any other human tumor. Mysthenia gravis (MG) is by far the most common autoimmune disease in thymoma patients. MG is characterized by muscle weakness due to autoantibodies against the acetylcholine receptor (AChR), and CD4+ AChR-specific T cells play a pivotal role for the production of these autoantibodies. About ...
متن کاملHow the application of human immunoglobulin in the treatment of myasthenia crisis changed the outcome of the disease.
INTRODUCTION Myasthenia gravis (MG) is an autoimmune disease characterized by weakness and fluctuating pathological tiredness of cross-striped muscle with improvement after rest. GOAL To compare the outcomes of treatment in myasthenic crisis therapy and conventional therapy with high doses of human immunoglobulin. Epidemiological research, mainly retrospective, partly prospective, descriptive...
متن کاملTacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China
BACKGROUND To determine the efficacy of low-dose, immediate-release tacrolimus in patients with myasthenia gravis (MG) with inadequate response to glucocorticoid therapy in a randomized, double-blind, placebo-controlled study. METHODS Eligible patients had inadequate response to glucocorticoids (GCs) after ⩾6 weeks of treatment with prednisone ⩾0.75 mg/kg/day or 60-100 mg/day. Patients were r...
متن کامل